Two Sigma Investments’s Global Cord Blood Corporation CO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-25,631
Closed -$124K 4186
2019
Q3
$124K Sell
25,631
-18,509
-42% -$97.1K ﹤0.01% 3281
2019
Q2
$255K Sell
44,140
-43,830
-50% -$289K ﹤0.01% 2954
2019
Q1
$618K Buy
87,970
+34,338
+64% +$227K ﹤0.01% 2139
2018
Q4
$346K Sell
53,632
-32,763
-38% -$209K ﹤0.01% 2361
2018
Q3
$604K Buy
+86,395
New +$649K ﹤0.01% 2323
2018
Q1
Sell
-19,554
Closed -$195K 3776
2017
Q4
$195K Sell
19,554
-74,967
-79% -$820K ﹤0.01% 2936
2017
Q3
$1.05M Buy
94,521
+67,221
+246% +$787K ﹤0.01% 1699
2017
Q2
$259K Buy
27,300
+4,386
+19% +$35K ﹤0.01% 2699
2017
Q1
$153K Sell
22,914
-200
-0.9% -$1.19K ﹤0.01% 2758
2016
Q4
$141K Sell
23,114
-3,600
-13% -$17.9K ﹤0.01% 2959
2016
Q3
$137K Sell
26,714
-220
-0.8% -$1.17K ﹤0.01% 3010
2016
Q2
$155K Sell
26,934
-5,669
-17% -$34.5K ﹤0.01% 2781
2016
Q1
$198K Sell
32,603
-42,871
-57% -$256K ﹤0.01% 2596
2015
Q4
$481K Buy
75,474
+6,663
+10% +$42.1K ﹤0.01% 1987
2015
Q3
$414K Buy
+68,811
New +$428K ﹤0.01% 1633

Other funds holding CO

Two Sigma Investments's CO Position: Q4 2019 in Review

Two Sigma Investments sold out of Global Cord Blood Corporation (CO) in Q4 2019, closing a stake of 25,631 shares — an estimated $124K sold.

Two Sigma Investments first reported a position in CO in Q3 2015 and held it in 15 quarters. The position peaked at $1.05M in Q3 2017. 35 funds tracked by Wall St. Rank hold CO as of Q4 2019.

  • Two Sigma Investments reported no remaining Global Cord Blood Corporation position as of Q4 2019 after selling out during the quarter.
  • Two Sigma Investments sold 25,631 Global Cord Blood Corporation shares in Q4 2019, an estimated $124K.
  • Two Sigma Investments first reported a position in Global Cord Blood Corporation in Q3 2015 and held it in 15 quarters.
  • Two Sigma Investments's Global Cord Blood Corporation position peaked at $1.05M in Q3 2017.
  • 35 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q4 2019.

Based on Two Sigma Investments's 13F filing for Q4 2019, filed 14 Feb 2020.